Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

C2N Diagnostics

Tracked across 9 events · 580 articles · First seen Feb 19, 2026 · Last active Sep 21, 2026

Sentiment
40
Attention
8
Events
9
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 70
Business
Impact: C2N Diagnostics received CAP accreditation, which validates its laboratory quality and is expected to support commercial expansion, broader payer coverage, and health system adoption for its CNSide CSF Assay Platform.
Jun 04, 2026 · 7 articles
4 60
Tech
The U.S. United States — Food and Drug Administration cleared the PrecivityAD2 blood test, developed by C2N Diagnostics, a startup founded by researchers at Washington University in St. Louis, to help evaluate Alzheimer's disease in…
Impact: Developer of the cleared PrecivityAD2 test; FDA clearance validates its mass spectrometry platform and opens a larger commercial market for Alzheimer's testing.
Aug 21, 2026 · 28 articles
2 60
Business
Impact: C2N Diagnostics is the distribution partner, offering the add-on through its consumer platform and leveraging its network of patient service centers. This enhances Quest's consumer health offerings and may drive additional test volume.
Aug 25, 2026 · 6 articles
6 40
Tech
Impact: C2N Diagnostics developed PrecivityAD2, a clinically available Alzheimer's blood test used in the study, and is a startup co-founded by Washington University in St. Louis researchers.
Feb 19, 2026 · 6 articles
4 60
Regulatory
Impact: C2N Diagnostics plans to offer the test under its AD-Detect brand, potentially increasing testing volumes and revenue.
Aug 24, 2026 · 7 articles
3 30
Business
Impact: C2N Diagnostics was honored with the Axtria Bedrock Honor for a 15-year partnership with Axtria and the successful implementation of Axtria SalesIQ, demonstrating a complex sales force alignment solution.
Jun 25, 2026 · 8 articles
8 40
Accidents
Impact: C2N Diagnostics' RealStar Filovirus Screen RT-PCR Kit 1.0 is being used to detect the Bundibugyo outbreak in the Democratic Republic of the Congo, and the firm has ramped up production.
May 18, 2026 · 505 articles
1 2
Business
IBM released a new global study through its Institute for Business Value examining the disconnect between the skills Chief Human Resource Officers say AI requires and those employees prioritize. The study surveyed 1,500 CHROs and…
Impact: C2N Diagnostics CHRO Cecilia McKenney provided a perspective emphasizing that AI is a tool for humans, adding a healthcare-sector voice to the study.
Sep 21, 2026 · 7 articles
6 0
Tech
Apr 14, 2026 · 6 articles
ERGEN INTELLIGENCE
Track C2N Diagnostics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.